Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DURABLE: Insulin Lispro Low Mixture vs Insulin Glargine in Type 2 Diabetes
NCT00548808Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2007
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 4 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Nov 2007; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00548808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548808.